Clinical Scorecard: CKM staging faces an early vascular test
At a Glance
| Category | Detail |
|---|---|
| Condition | Cardiovascular-Kidney-Metabolic Syndrome |
| Key Mechanisms | Association of CKM stages with cardiovascular health scores and early carotid arterial injury. |
| Target Population | Young adults aged 23 years (mean age) from the FF-CHAYA study. |
| Care Setting | Cross-sectional study assessing cardiovascular health and arterial injury. |
Key Highlights
- CKM stages classified as stage 0 to stage 3 based on risk factors.
- Mean Life’s Essential 8 scores decreased with advanced CKM stages.
- Higher carotid intima-medial thickness associated with more advanced CKM stages.
- Sensitivity analysis showed no statistical differences in health-behavior components across CKM stages.
- Study cohort may not be representative due to oversampling from disadvantaged backgrounds.
Guideline-Based Recommendations
Diagnosis
- Use the adapted CKM staging framework to classify cardiovascular-kidney-metabolic risk.
Management
- Monitor cardiovascular health using Life’s Essential 8 metrics.
Monitoring & Follow-up
- Assess carotid arterial injury through ultrasonography.
Risks
- Increased risk of cardiovascular disease with advanced CKM stages.
Patient & Prescribing Data
Participants from the FF-CHAYA study, predominantly young adults.
Focus on lifestyle modifications to improve Life’s Essential 8 scores.
Clinical Best Practices
- Incorporate CKM staging in routine assessments of young adults.
- Utilize carotid ultrasonography for early detection of arterial injury.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
